青少年和成年人中耐大环内酯类肺炎支原体肺炎：临床特征、药敏情况和治疗效果。
Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.
机构信息
Department of Internal Medicine 1.
出版信息
Antimicrob Agents Chemother. 2013 Oct;57(10):5181-5. doi: 10.1128/AAC.00737-13. Epub 2013 Jul 29.
Abstract
We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P = 0.0361 and P = 0.0237, respectively).
摘要
我们研究了 30 例大环内酯类耐药肺炎支原体肺炎患者和 43 例青少年和成人大环内酯类敏感肺炎支原体肺炎患者的临床特征差异。两组患者的临床表现无差异。在大环内酯类耐药肺炎支原体肺炎患者中，接受喹诺酮类和米诺环素治疗的患者比接受大环内酯类治疗的患者治疗效果更好（分别为 P = 0.0361 和 P = 0.0237）。
相似文献
1
Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.青少年和成年人中耐大环内酯类肺炎支原体肺炎：临床特征、药敏情况和治疗效果。
Antimicrob Agents Chemother. 2013 Oct;57(10):5181-5. doi: 10.1128/AAC.00737-13. Epub 2013 Jul 29.
2
Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.与大环内酯类药物治疗失败相关的严重耐大环内酯类肺炎支原体肺炎
J Microbiol Immunol Infect. 2016 Feb;49(1):127-30. doi: 10.1016/j.jmii.2014.11.003. Epub 2014 Nov 11.
3
Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.米诺环素、强力霉素和托舒沙星对大环内酯类耐药肺炎支原体的杀菌动力学。
Int J Antimicrob Agents. 2017 Aug;50(2):255-257. doi: 10.1016/j.ijantimicag.2017.02.027. Epub 2017 Jun 1.
4
Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
J Infect Chemother. 2000 Sep;6(3):188. doi: 10.1007/s101560070021.
5
Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
J Infect Chemother. 2000 Sep;6(3):148-50. doi: 10.1007/s101560070013.
6
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.阿奇霉素、克拉霉素、米诺环素及妥舒沙星对小儿耐大环内酯类及大环内酯类敏感肺炎支原体肺炎的治疗效果
PLoS One. 2017 Mar 13;12(3):e0173635. doi: 10.1371/journal.pone.0173635. eCollection 2017.
7
A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.大环内酯类药物敏感与耐药肺炎支原体感染患儿的临床对比研究。
J Infect Chemother. 2009 Dec;15(6):380-3. doi: 10.1007/s10156-009-0715-7.
8
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.青少年社区获得性肺炎中耐大环内酯类肺炎支原体。
BMC Infect Dis. 2012 May 31;12:126. doi: 10.1186/1471-2334-12-126.
9
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.大环内酯类抗生素治疗儿童肺炎支原体肺炎中基因决定的大环内酯类耐药的临床疗效。
Respirology. 2012 Feb;17(2):354-62. doi: 10.1111/j.1440-1843.2011.02102.x.
10
Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant Isolated from Adults in Jeju Island.济州岛成人分离的大环内酯类耐药的社区获得性肺炎的流行率和临床特征。
Microb Drug Resist. 2019 May;25(4):577-581. doi: 10.1089/mdr.2018.0295. Epub 2018 Nov 28.
引用本文的文献
1
Therapeutic efficacy of lascufloxacin in patients with pneumonia.拉斯库氟沙星对肺炎患者的治疗效果。
Microbiol Spectr. 2025 Aug 5;13(8):e0025525. doi: 10.1128/spectrum.00255-25. Epub 2025 Jun 18.
2
Recent Macrolide Resistance Pattern of Mycoplasma Pneumonia in the World: A Systematic Review and Meta-Analysis.全球肺炎支原体近期的大环内酯类耐药模式：一项系统评价与Meta分析
Iran J Public Health. 2025 Mar;54(3):530-541. doi: 10.18502/ijph.v54i3.18246.
3
Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia.肺炎支原体肺炎患儿发热持续时间的治疗方式
Sci Rep. 2025 Apr 28;15(1):14860. doi: 10.1038/s41598-025-99537-0.
4
Pulmonary thromboembolism due to Mycoplasma pneumoniae in children: a case report and literature review.儿童支原体肺炎所致肺血栓栓塞症：1例报告并文献复习
BMC Pediatr. 2024 Dec 19;24(1):816. doi: 10.1186/s12887-024-05283-z.
5
Clinical and Epidemiologic Features of Infection Among Adults Hospitalized with Community-acquired Pneumonia.社区获得性肺炎成年住院患者感染的临床和流行病学特征
Int J Med Sci. 2024 Nov 11;21(15):3003-3009. doi: 10.7150/ijms.99233. eCollection 2024.
6
New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis.新代四环素类药物治疗儿童重症耐大环内酯类肺炎支原体肺炎：回顾性分析。
BMC Infect Dis. 2024 Oct 16;24(1):1166. doi: 10.1186/s12879-024-10070-3.
7
Laboratory diagnosis and treatment of infection in children: a review.儿童感染的实验室诊断与治疗：综述
Ann Med. 2024 Dec;56(1):2386636. doi: 10.1080/07853890.2024.2386636. Epub 2024 Aug 3.
8
Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.儿童肺炎支原体肺炎治疗面临的挑战。
Eur J Pediatr. 2024 Jul;183(7):3001-3011. doi: 10.1007/s00431-024-05519-1. Epub 2024 Apr 18.
9
Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia.肺炎支原体肺炎患儿呼吸道病毒混合感染的临床意义。
BMC Pulm Med. 2022 May 30;22(1):212. doi: 10.1186/s12890-022-02005-y.
10
Clinical Characteristics of Macrolide-Refractory Pneumonia in Korean Children: A Multicenter Retrospective Study.韩国儿童大环内酯类难治性肺炎的临床特征：一项多中心回顾性研究
J Clin Med. 2022 Jan 8;11(2):306. doi: 10.3390/jcm11020306.
本文引用的文献
1
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.大环内酯类、米诺环素和托氟沙星治疗儿童耐大环内酯类肺炎支原体肺炎的疗效。
Antimicrob Agents Chemother. 2013 May;57(5):2252-8. doi: 10.1128/AAC.00048-13. Epub 2013 Mar 4.
2
Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.米诺环素或强力霉素对大环内酯类耐药肺炎支原体感染的快速疗效：2011 年日本儿童暴发疫情中的研究
Clin Infect Dis. 2012 Dec;55(12):1642-9. doi: 10.1093/cid/cis784. Epub 2012 Sep 12.
3
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.青少年社区获得性肺炎中耐大环内酯类肺炎支原体。
BMC Infect Dis. 2012 May 31;12:126. doi: 10.1186/1471-2334-12-126.
4
Influence of age on the clinical differentiation of atypical pneumonia in adults.年龄对成人非典型性肺炎临床鉴别诊断的影响。
Respirology. 2012 Oct;17(7):1073-9. doi: 10.1111/j.1440-1843.2012.02188.x.
5
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.大环内酯类抗生素治疗儿童肺炎支原体肺炎中基因决定的大环内酯类耐药的临床疗效。
Respirology. 2012 Feb;17(2):354-62. doi: 10.1111/j.1440-1843.2011.02102.x.
6
Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.成人肺炎支原体肺炎快速诊断方法的临床应用潜力。
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):439-46. doi: 10.1007/s10096-010-1107-8.
7
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.中国成人和青少年呼吸道感染肺炎支原体分离株中大环内酯类耐药率高。
Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.
8
A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.大环内酯类药物敏感与耐药肺炎支原体感染患儿的临床对比研究。
J Infect Chemother. 2009 Dec;15(6):380-3. doi: 10.1007/s10156-009-0715-7.
9
Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing.肺炎支原体肺炎的影像学特征：鉴别诊断及表现时机
BMC Med Imaging. 2009 Apr 29;9:7. doi: 10.1186/1471-2342-9-7.
10
Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography.通过薄层 CT 对细菌性和非细菌性社区获得性肺炎进行鉴别。
Eur J Radiol. 2009 Dec;72(3):388-95. doi: 10.1016/j.ejrad.2008.08.004. Epub 2008 Oct 2.
Zotero 插件